Search

Your search keyword '"Valent A"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Valent A" Remove constraint Author: "Valent A" Journal leukemia Remove constraint Journal: leukemia
164 results on '"Valent A"'

Search Results

1. Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

3. The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

4. CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS

6. Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis

7. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

9. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

10. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

14. KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis

17. Pharmacologic inhibition of STAT5 in acute myeloid leukemia

18. Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis

21. SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

27. Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia

31. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

32. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

35. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

36. Refined diagnostic criteria for bone marrow mastocytosis : a proposal of the European competence network on mastocytosis

37. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

39. Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia

40. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

41. Monosomal karyotype in MDS: explaining the poor prognosis?

42. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

43. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

44. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

45. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

48. Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Catalog

Books, media, physical & digital resources